SCHEMBL5352380

SCHEMBL5352380

Cc1oc(-c2ccccc2)nc1CCOc1[c]c(CNC(=O)c2ccccc2-c2ccccc2)ccc1

nearest known ligand 0.48

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 19/20 0.48
PPARA Q07869 12/20 0.48
PPARD Q03181 1/20 0.44
KLKB1 P03952 1/20 0.44
KLK1 P06870 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5351857 0.84 TP53 (0.59) PPARGPPARA
SCHEMBL5730171 0.84 PPARG (0.62) PPARGPPARA
SCHEMBL5729735 0.83 PPARG (0.49) PPARGPPARA
SCHEMBL5355635 0.83 MAPT (0.52) PPARGPPARA
SCHEMBL5363280 0.82 PPARG (0.49) PPARGPPARA
SCHEMBL5350843 0.82 PPARG (0.51) PPARGPPARA
SCHEMBL4894205 0.82 PPARG (0.49) PPARGPPARA
SCHEMBL5730014 0.80 PPARG (0.53) PPARGPPARA
SCHEMBL5350639 0.80 PPARG (0.54) PPARGPPARAPPARD
SCHEMBL5730668 0.79 PPARG (0.54) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7282501-B2 Modulators of peroxisome proliferator activated receptors (PPAR) ELI LILLY AND COMPANY (US) 2007-10-16 US claimed
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) ELI LILLY AND COMPANY 2005-04-07 US claimed
EP-1401434-B1 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS (PPAR) LILLY CO ELI (US) 2006-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075378-A1 Modulators of peroxisome proliferator activated receptors (ppar) PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.